BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 11935085)

  • 1. Hepatocellular carcinoma: an Asian perspective.
    Teo EK; Fock KM
    Dig Dis; 2001; 19(4):263-8. PubMed ID: 11935085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study.
    Park JW; Chen M; Colombo M; Roberts LR; Schwartz M; Chen PJ; Kudo M; Johnson P; Wagner S; Orsini LS; Sherman M
    Liver Int; 2015 Sep; 35(9):2155-66. PubMed ID: 25752327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.
    Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL
    Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
    Lim SG; Mohammed R; Yuen MF; Kao JH
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreasing incidence of hepatocellular carcinoma among children following universal hepatitis B immunization.
    Chang MH
    Liver Int; 2003 Oct; 23(5):309-14. PubMed ID: 14708890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma in the Asia pacific region.
    Yuen MF; Hou JL; Chutaputti A;
    J Gastroenterol Hepatol; 2009 Mar; 24(3):346-53. PubMed ID: 19220670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
    Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma in viral hepatitis: improving standard therapy.
    Masuzaki R; Yoshida H; Tateishi R; Shiina S; Omata M
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1137-51. PubMed ID: 19187872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of hepatocellular carcinoma in children in Khon Kaen before and after national hepatitis B vaccine program.
    Wichajarn K; Kosalaraksa P; Wiangnon S
    Asian Pac J Cancer Prev; 2008; 9(3):507-9. PubMed ID: 18990029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
    Kew MC
    Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral hepatitis and hepatocellular carcinoma.
    Sallie R; Di Bisceglie AM
    Gastroenterol Clin North Am; 1994 Sep; 23(3):567-79. PubMed ID: 7989095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls.
    Chang MH; Shau WY; Chen CJ; Wu TC; Kong MS; Liang DC; Hsu HM; Chen HL; Hsu HY; Chen DS;
    JAMA; 2000 Dec; 284(23):3040-2. PubMed ID: 11122592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secular trends were considered in the evaluation of universal hepatitis B vaccination in Taiwan.
    Chang CH; Lin JW; Tu YK
    J Clin Epidemiol; 2015 Apr; 68(4):405-11. PubMed ID: 25660961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma.
    Desjardins LA
    Clin J Oncol Nurs; 2002; 6(2):107-8. PubMed ID: 11889672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatocellular carcinoma: a preventable cancer].
    Viviani S; Jack A; Bah E; Montesano R
    Epidemiol Prev; 1997; 21(2):129-36. PubMed ID: 9378180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and natural history of hepatocellular carcinoma.
    McGlynn KA; London WT
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):3-23. PubMed ID: 15757802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
    Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatocellular carcinoma in Korea: introduction and overview].
    Park JW
    Korean J Gastroenterol; 2005 Apr; 45(4):217-26. PubMed ID: 15843747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic, clinical, and virological characteristics of hepatocellular carcinoma in Asia: survey of 414 patients from four countries.
    Wang BE; Ma WM; Sulaiman A; Noer S; Sumoharjo S; Sumarsidi D; Tandon BN; Nakao K; Mishiro S; Miyakawa Y; Akahane Y; Suzuki H
    J Med Virol; 2002 Jul; 67(3):394-400. PubMed ID: 12116033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatocellular carcinoma--epidemiology and treatment].
    Małkowski P; Pacholczyk M; Łagiewska B; Adadyński L; Wasiak D; Kwiatkowski A; Chmura A; Czerwiński J
    Przegl Epidemiol; 2006; 60(4):731-40. PubMed ID: 17682755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.